Application no. and date | 23154757.1 (espacenet) (Federated) (European Patent Register), 20160509 | Patent/reg. no. and date | DK/EP 4212152, 20250430 | Publication date | 20230719 | Priority no. and date | US 201562159703 P, 20150511 | EP pub. no. and date |
EP 4212152 20230719 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | V491684DK00 | Inventor | RIZKALA, Adel Redmond,
East Hannover, 07936, US, SHI, Victor Chengwei,
East Hanover, 07936, US, CHEN, Fabian,
East Hanover, 07936, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/225 (2006.01) , A61K 31/41 (2006.01) , A61P 9/04 (2006.01) | Title | SACUBITRIL-VALSARTAN-DOSERINGSREGIME TIL BEHANDLING AF KRONISK SYSTOLISK HJERTESVIGT | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|